Justin Tiao

Justin Tiao

Auto-generated profile, based on publicly available information

Justin Tiao

Icahn School of Medicine at Mount Sinai

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2023 in Clinical Orthopaedics and Related Research
Verified
Journal Article
Closed access
JTJustin Bs Tiao
Justin Bs Tiao
KWKevin Wang
Kevin Wang
MHMichael Bs Herrera
Michael Bs Herrera
RRRenee Ba Ren
Renee Ba Ren
ARAshley M. Bs Rosenberg
Ashley M. Bs Rosenberg
JPJashvant Poeran
Jashvant Poeran
Background: Demand for platelet-rich plasma (PRP) injections for osteoarthritis has dramatically increased in recent years despite conflicting evidence regarding its efficacy and highly variable pricing in the top orthopaedic centers in the United States, because PRP is typically not covered by insurance. A previous study investigating the mean price of PRP injections obtained information only from centers advertising online the availability of PRP injections. Thus, there is a need for further clarification of the overall availability and variability in cost of PRP injections in the orthopaedic community as well as an analysis of relevant regional demographic and hospital characteristics that could be associated with PRP pricing. Questions/purposes: Our study purposes were to (1) report the availability and price variation of knee PRP injections at top-ranked United States orthopaedic centers, (2) characterize the availability of pricing information for a PRP injection over the telephone, (3) determine whether hospital characteristics (Orthopaedic Score [U.S. News & World Report measure of hospital orthopaedic department performance], size, teaching status, and rural-urban status) were associated with PRP injection availability and pricing, and (4) characterize the price variation, if it exists, of PRP injections in three metropolitan areas and individual institutions. Methods: In this prospective study, a scripted telephone call to publicly listed clinic telephone numbers was used to determine the availability and price estimate (amount to be paid by the patient) of a PRP injection for knee osteoarthritis from the top 25 hospitals from each United States Census region selected from the U.S. News & World Report ranking of best hospitals for orthopaedics. Univariable analyses examined factors associated with PRP injection availability and willingness to disclose pricing, differences across regions, and the association between hospital characteristics (Orthopaedic Score, size, teaching status, and rural-urban status) and pricing. The Orthopaedic Score is a score assigned to each hospital by U.S. News & World Report as a measure of hospital performance based partly on patient outcomes, with higher scores indicating better outcomes. Results: Overall, 87% (87 of 100) of respondents stated they offered PRP injections. Pricing ranged from USD 350 to USD 2815 (median USD 800) per injection, with the highest prices in the Northeast. The largest price range was in the Midwest, where more than two-thirds of PRP injections given at hospitals that disclosed pricing cost USD 500 to USD 1000. Of the hospitals that offered PRP injections, 68% (59 of 87) were willing to disclose price information over the telephone. PRP injection pricing was inversely correlated with hospital Orthopaedic Score (-3% price change [95% CI -5% to -1%]; p = 0.01) and not associated with any of the other hospital characteristics that were studied, such as patient population median income and total hospital expenses. An intracity analysis revealed wide variations in PRP pricing in all metropolitan areas that were analyzed, ranging from a minimum of USD 300 within 10 miles of metropolitan area B to a maximum of USD 1269 within 20 miles of metropolitan area C. Conclusion: We found that although PRP injections are widely available, pricing continues to be a substantial financial burden on patients, with large price variability among institutions. We also found that if patients are willing to shop around in a metropolitan area, there is potential to save a meaningful amount of money. Clinical Relevance: As public interest in biologics in orthopaedic surgery increases, knowledge of its pricing should be clarified to consumers. The debated efficacy of PRP injections, combined with our findings that it is an expensive out-of-pocket procedure, suggests that PRP has limited cost-effectiveness, with variable, discrete pricing. As such, the price of PRP injections should be clearly disclosed to patients so they can make informed healthcare decisions.

24 April 2023 in Arthroscopy
Verified
Journal Article
Closed access
JTJustin Tiao
Justin Tiao
KWKevin Wang
Kevin Wang
MHMichael Herrera
Michael Herrera
ARAshley Rosenberg
Ashley Rosenberg
ACAndrew Carbone
Andrew Carbone
SAShawn G. Anthony
Shawn G. Anthony

1 December 2022 in The American Journal of Sports Medicine
Verified
Journal Article
Closed access
JTJustin Tiao
Justin Tiao
KWKevin Wang
Kevin Wang
ACAndrew D. Carbone
Andrew D. Carbone
MHMichael Herrera
Michael Herrera
NZNicole Zubizarreta
Nicole Zubizarreta
SAShawn G. Anthony
Shawn G. Anthony
Background: Anterior cruciate ligament reconstruction (ACLR) is a commonly performed orthopaedic procedure. The volume and cost of ACLR procedures are increasing annually, but the drivers of these cost increases are not well described. Purpose: To analyze the modifiable drivers of total health care utilization (THU), immediate procedure reimbursement, and surgeon reimbursement for patients undergoing ACLR using a large national commercial insurance database from 2013 to 2017. Study Design: Descriptive epidemiology study. Methods: For this study, the cohort consisted of patients identified in the MarketScan Commercial Claims and Encounters database who underwent outpatient arthroscopic ACLR in the United States from 2013 to 2017. Patients with Current Procedural Terminology code 29888 were included. THU was defined as the sum of any payment related to the ACLR procedure from 90 days preoperatively to 180 days postoperatively. A multivariable model was utilized to describe the patient- and procedure-related drivers of THU, immediate procedure reimbursement, and surgeon reimbursement. Results: There were 34,862 patients identified. On multivariable analysis, the main driver of THU and immediate procedure reimbursement was an outpatient hospital as the surgical setting (US$6789 increase in THU). The main driver of surgeon reimbursement was an out-of-network surgeon (US$1337 increase). Health maintenance organization as the insurance plan type decreased THU, immediate procedure reimbursement, and surgeon reimbursement (US$955, US$108, and US$38 decrease, respectively, compared with preferred provider organization; P < .05 for all). Conclusion: Performing procedures in more cost-efficient ambulatory surgery centers had the largest effect on decreasing health care expenditures for ACLR. Health maintenance organizations aided in cost-optimization efforts as well, but had a minor effect on surgeon reimbursement. Overall, this study increases transparency into what drives reimbursement and serves as a foundation for how to decrease health care expenditures related to ACLR.

30 September 2025 in Global Spine Journal
Verified
Journal Article
Open access
AYAlexander Yu
Alexander Yu
JTJustin Tiao
Justin Tiao
CCCharlene W. Cai
Charlene W. Cai
JHJonathan J. Huang
Jonathan J. Huang
KMKareem Mohamed
Kareem Mohamed
ADAo Spine Knowledge Forum Degenerative
Ao Spine Knowledge Forum Degenerative
Study Type: Systematic Scoping Review. Introduction: Radiographic assessment is crucial for diagnosing symptomatic pseudarthrosis and evaluating spinal fusion outcomes, yet no consensus exists on defining successful lumbar fusion. This scoping review presents criteria for imaging-based assessment after posterolateral and interbody lumbar fusion, aiming to guide consistent evaluation methods. Methods: Following PRISMA guidelines, a comprehensive search of Medline, Embase, and Scopus identified eligible randomized controlled trials and Federal Drug Administration clinical trials involving lumbar fusion. Studies on revision surgeries, non-lumbar fusions, adult spinal deformity, traumatic fractures, tumors, infections, or lacking defined fusion assessment methods were excluded. Data extraction focused on classification and descriptive systems of fusion evaluation, analyzing parameters such as bony bridging, angular motion, translation, hardware failure, cage migration, radiolucency, and cleft within the fusion mass. Results: A total of 142 articles (1995-2024) were reviewed. Computerized tomography was the most common imaging modality (102, 71.8%), followed by static (96, 67.6%) and dynamic radiographs (88, 62%). Descriptive criteria were used in 108 studies (76.1%) and classification systems in 47 (33.1%). Interbody fusion was assessed in 90 articles (63.4%) and posterolateral fusion in 68 (47.9%). Bony bridging continuity was the most reported descriptive criterion (105, 73.9%), followed by angular motion (72, 50.7%) and translation (43, 30.3%). Radiolucency was reported around the cage (31, 21.8%), pedicle screws (17, 11.9%), and within the fusion mass (36, 25.4%) to describe nonunion. Common classification systems included Bridwell (10 studies), Brantigan (9), and Lenke (9). Conclusions: This scoping review highlights the variability in lumbar fusion assessment across RCTs and FDA trials. Over time, assessment methods have evolved from static radiographs to greater use of dynamic imaging and classification systems in the mid-2000s, with CT emerging as the dominant modality in the past decade. Despite these advancements, fusion assessment criteria remain inconsistent across studies.

27 October 2023 in Arthroscopy
Verified
Journal Article
Closed access
JTJustin Tiao
Justin Tiao
ARAshley M. Rosenberg
Ashley M. Rosenberg
THTimothy Hoang
Timothy Hoang
BZBashar Zaidat
Bashar Zaidat
KWKevin Wang
Kevin Wang
SAShawn G. Anthony
Shawn G. Anthony

19 October 2025 in JOR SPINE
Verified
Journal Article
Open access
NBNeharika Bhadouria
Neharika Bhadouria
JTJustin Tiao
Justin Tiao
ABAngelica Baburova
Angelica Baburova
CJCharu Jain
Charu Jain
BWBowen Wang
Bowen Wang
JIJames Iatridis
James Iatridis
Background: Intervertebral disc degeneration (IVDD) is a major cause of global disability that increases with age. IVD age may affect its injury susceptibility, yet few studies examine spine biomechanical changes with age, fewer address multiple injury types, and none investigate the interplay between age and injury. Methods: An ex vivo mouse lumbar spine biomechanical study to determine the effects of age, injury, and their interaction. IVDs of 4, 12, and 24 months' mice were subjected to two injury types: Full disc puncture (DP) mimicking advanced IVDD and annulus fibrosus and endplate (AF + EP) injury simulating herniation with endplate junction failure. Spines were tested biomechanically, analyzed radiologically for IVD dimensions, and with FTIR and histology for biochemical content. Results: Both age and injury significantly altered biomechanical properties of IVDs. Injury had a greater effect than age, and DP caused larger changes than AF + EP injury. Injury and age exhibited an interactive effect, resulting in more pronounced biomechanical dysfunction in middle‐aged (12 months) and geriatric IVDs (24 months), likely due to age‐related loss of proteoglycans and collagen denaturation shown with FTIR and histology. Conclusions: We conclude that both age and injury independently and synergistically affect ex vivo biomechanical properties of mouse lumbar spine. The more severe biomechanical change in middle‐aged and geriatric mouse lumbar spines suggests similar injuries may cause greater spinal dysfunction in individuals of comparable ages. These findings provide context for future in vivo studies investigating long‐term effects of acute spine injuries.